Fluzone 2025 Southern Hemisphere Injectable Product
RxNorm concept 2709017, branded dose form group (sbdg).
- RxCUI
- 2709017
- Term type
- Branded dose form group (SBDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2709017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Fluzone 2025 Southern Hemisphere (BN, has ingredient)
- influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Product (SCDG, tradename of)
- influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen Injectable Product (SCDGP, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2709017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2709017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2709017. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.